Clinical trial
Study to Evaluate the Safety and Immunogenicity of an Investigational…
NCT00327665 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00327665 |
|---|---|
| Title | Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population |
| Official title | A Phase I/II, Randomized, Observer Blinded Study to Evaluate and Compare the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline Biologicals' Investigational Pneumococcal Vaccine Formulations Versus a Licensed Non-GlaxoSmithKline Biologicals' Vaccine and GlaxoSmithKline Biologicals'… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Infections, Streptococcal |
| Intervention type | Biological |
| Interventions | 11-valent pneumococcal vaccine GSK513026, Pneumo 23™, Placebo, 10-valent pneumococcal vaccine GSK513026 |
| Enrollment | 335 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 8, 2007 |
| First posted | May 18, 2006 |
| Last update posted | May 8, 2017 |
| Countries | Belgium, Finland, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: